PMGC HOLDINGS INC. Interest Income, Other
PMGC HOLDINGS INC. (ELAB) reported Interest Income, Other of $5.56 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2024-03-29
- PMGC HOLDINGS INC. interest income, other for the quarter ending 2023-12-31 was -$5.48M.
- PMGC HOLDINGS INC. interest income, other for the quarter ending 2023-09-30 was $25.00K, a 99.21% decline year-over-year.
- PMGC HOLDINGS INC. interest income, other for the quarter ending 2022-12-31 was -$3.24M.
- PMGC HOLDINGS INC. interest income, other for the quarter ending 2022-09-30 was $3.16M.
- PMGC HOLDINGS INC. interest income, other for fiscal 2023 was $5.56K, a 27.76% decline from fiscal 2022.
- PMGC HOLDINGS INC. interest income, other for fiscal 2022 was $7.70K.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month | Interest Income, Other 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$5.48M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$5.45M derived: sum of 2 quarters · filed 2024-03-29 | $5.56K 10-K · filed 2024-03-29 | |
| 2023-09-30 | $25.00K 10-Q · filed 2023-12-11 | $5.48M 10-Q · filed 2023-12-11 | ||
| 2022-12-31 | -$3.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$78.30K derived: sum of 2 quarters · filed 2024-03-29 | $7.70K 10-K · filed 2024-03-29 | |
| 2022-09-30 | $3.16M 10-Q · filed 2023-12-11 | $3.25M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |